NIMC
TEVA icon

NWQ Investment Management Company’s Teva Pharmaceuticals TEVA Stock Holding History

NWQ Investment Management Company’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-178,402
Closed -$3.05M – 178
2018
Q1 		$3.05M Sell
178,402
-1,025,784
-85% -$20M 0.05% 154
2017
Q4 		$22.8M Buy
1,204,186
+250,732
+26% +$3.77M 0.3% 105
2017
Q3 		$16.8M Sell
953,454
-13,825
-1% -$311K 0.21% 120
2017
Q2 		$32.1M Buy
967,279
+41,100
+4% +$1.27M 0.44% 88
2017
Q1 		$29.8M Buy
926,179
+67,302
+8% +$2.3M 0.39% 93
2016
Q4 		$31.1M Sell
858,877
-1,804,754
-68% -$72.1M 0.42% 86
2016
Q3 		$123M Buy
2,663,631
+985,790
+59% +$51.4M 1.78% 7
2016
Q2 		$84.3M Sell
1,677,841
-283,367
-14% -$15.1M 1.45% 19
2016
Q1 		$105M Buy
1,961,208
+581,065
+42% +$34.1M 1.64% 14
2015
Q4 		$90.6M Sell
1,380,143
-1,028,683
-43% -$63.6M 1.4% 17
2015
Q3 		$136M Sell
2,408,826
-575,780
-19% -$37.3M 2.09% 4
2015
Q2 		$171M Sell
2,984,606
-684,473
-19% -$42.2M 2.36% 3
2015
Q1 		$229M Sell
3,669,079
-342,108
-9% -$19.9M 2.85% 1
2014
Q4 		$231M Sell
4,011,187
-686,930
-15% -$38.3M 2.77% 1
2014
Q3 		$249M Sell
4,698,117
-387,600
-8% -$20.5M 2.73% 2
2014
Q2 		$267M Sell
5,085,717
-1,208,938
-19% -$61.8M 2.68% 4
2014
Q1 		$333M Buy
6,294,655
+302,295
+5% +$14M 2.91% 4
2013
Q4 		$240M Sell
5,992,360
-140,553
-2% -$5.53M 2.1% 18
2013
Q3 		$232M Sell
6,132,913
-645,626
-10% -$25.2M 2.2% 17
2013
Q2 		$266M Buy
+6,778,539
New +$264M 2.31% 17

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

NWQ Investment Management Company's TEVA Position: Q2 2018 in Review

NWQ Investment Management Company sold out of Teva Pharmaceuticals (TEVA) in Q2 2018, closing a stake of 178,402 shares — an estimated $3.05M sold.

NWQ Investment Management Company first reported a position in TEVA in Q2 2013 and held it in 20 quarters. The position peaked at $333M in Q1 2014. 540 funds tracked by Wall St. Rank hold TEVA as of Q2 2018.

  • NWQ Investment Management Company reported no remaining Teva Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • NWQ Investment Management Company sold 178,402 Teva Pharmaceuticals shares in Q2 2018, an estimated $3.05M.
  • NWQ Investment Management Company first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 20 quarters.
  • NWQ Investment Management Company's Teva Pharmaceuticals position peaked at $333M in Q1 2014.
  • 540 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2018.

Based on NWQ Investment Management Company's 13F filing for Q2 2018, filed 14 Aug 2018.